Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,895,306 papers from all fields of science
Search
Sign In
Create Free Account
Adecatumumab
A recombinant human IgG1 monoclonal antibody (MoAb) directed against the tumor associated antigen (TAA) epithelial cell adhesion molecule (EpCAM…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Narrower (1)
MT201
antigen binding
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer
D. Santini
,
B. Vincenzi
,
+15 authors
G. Tonini
2012
Corpus ID: 109931624
M. Schmidt1, D. Rüttinger2,3, M. Sebastian4, C. A. Hanusch5, N. Marschner6, P. A. Baeuerle2,3, A. Wolf2,3, G. Göppel2,3, D…
Expand
2010
2010
EpCAM-specific immunotherapy with human monoclonal antibody adecatumumab (MT201) in chemotherapy-resistant ovarian cancer cell lines.
C. Richter
,
E. Cocco
,
+7 authors
A. Santin
2010
Corpus ID: 73907279
e15524 Background: To evaluate the expression of epithelial cell adhesion molecule (EpCAM) and to determine the cytotoxic…
Expand
2010
2010
Gateways to clinical trials.
A. Tomillero
,
M. A. Moral
Methods and Findings in Experimental and Clinical…
2010
Corpus ID: 31023199
[¹¹C]RAC; (18)F-Fluoromisonidazole; 89-12; 9-[¹⁸F]Fluoropropyl-(+)-dihydrotetrabenazine; Adalimumab, Adecatumumab, ADMVA, ADXS-11…
Expand
2009
2009
Gateways to clinical trials.
A. Tomillero
,
M. A. Moral
Methods and Findings in Experimental and Clinical…
2009
Corpus ID: 22145781
[Methoxy-(11)C]PD-153035, 2-Methoxyestradiol; Adalimumab, Adecatumumab, Adefovir dipivoxil, ADH-1, ADX-10059, Aflibercept, AIR…
Expand
2007
2007
Apparent lack of immunogenicity of human antibody adecatumumab in breast and prostate cancer patients
A. Wolf
2007
Corpus ID: 85786485
B49 The human antibody adecatumumab (MT201) targets the tumor-associated antigen EpCAM (CD326). Adecatumumab is currently…
Expand
2006
2006
Adecatumumab promising for breast and prostate cancer
2006
Corpus ID: 195118497